Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acebrophylline + montelukast + desloratadine
- Development stage
- Unknown
- Lead developer
- Med Science Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Airline-AMD is a fixed-dose combination product marketed by Med Science Pharma, a pharmaceutical distributor based in India. It contains three active ingredients: acebrophylline, montelukast, and desloratadine. Acebrophylline acts as a bronchodilator and mucolytic by inhibiting phosphodiesterase and reducing bronchial hyperresponsiveness. Montelukast is a selective leukotriene receptor antagonist that reduces airway edema and inflammation. Desloratadine is a non-sedating, long-acting H1-receptor antagonist that provides relief from allergic symptoms. This combination is typically indicated for the management of chronic obstructive pulmonary disease (COPD), asthma, and allergic rhinitis, particularly when associated with excessive mucus production and allergic triggers.
- Brand names
- Airline-AMD
- Other names
- Acebrophylline, Montelukast and Desloratadine Tablet
02
Targets
UreaseSucrase-IsomaltaseHRH1 (Histamine H1 Receptor)CYSLTR1 (Cysteinyl-leukotriene type 1 receptor)ADOR (Adenosine receptors)
Beyond the preview
Go deeper on acebrophylline + montelukast + desloratadine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acebrophylline + montelukast + desloratadine.